Skip to content

Comparison of CO2 Laser plus Antifungal Nail Lacquer versus Antifungal Nail Lacquer Alone in Treating Fungal Nail Infection

Study of the effectiveness of fractional CO2 laser therapy combined with 8 percent ciclopirox nail lacquer Vs ciclopirox nail lacquer alone in Onychomycosis Randomized Control Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095558
Enrollment
72
Registered
2025-10-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B351- Tinea unguium

Interventions

Intervention1: Fractional CO2 Laser + Ciclopirox 8% nail lacquer: Participants will receive Fractional CO2 laser therapy applied to affected nails at baseline, in addition to daily topical application

Sponsors

Institute of Naval Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria Age between 18 to 75 years. Involvement of two or more fingernails or toenails. Positive KOH microscopy for fungal elements. Treatment-na ve patients (no prior antifungal treatment for onychomycosis).

Exclusion criteria

Exclusion criteria: Age below 18 years. Involvement of less than two fingernails or toenails. Negative KOH mount for fungal elements. Female subjects who are pregnant, nursing, or planning to become pregnant during the study period. Presence of other conditions causing nail dystrophy such as psoriasis, eczema, lichen planus, or immunodeficiency states (e.g., HIV infection, post-organ transplantation, long-term immunosuppressive therapy, chemotherapy, or radiotherapy). Any significant disease of the hepatic, renal, endocrine (including diabetes mellitus), or immune systems, or other medical conditions which may interfere with or confound study assessments (e.g., pre-existing chronic foot pain, neurologic deficit, or skin disease/injury of the treated foot).

Design outcomes

Primary

MeasureTime frame
Clinical cure improvement in nail appearance, reduction in discoloration and thickness, assessed at 12 weeks and 24 weeks. Mycological cure negative KOH microscopy and culture at 12 weeks and 24 weeks.Timepoint: 12 AND 24 WEEKS POST INITIATION OF TREATMENT

Secondary

MeasureTime frame
To evaluate patient-reported outcomes including pain, discomfort, and cosmetic improvement.Timepoint: 24 WEEKS POST INITIATION OF TREATMENT

Countries

India

Contacts

Public ContactAnkush Kumar Somvanshi

Institute Of Naval Medicine, INHS Asvini

kharayatveena@gmail.com8360610643

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026